Healthcare
COLTENE HOLDING AG(CLHLF)
Live Price
Offline$61.16
+0.00% today
1Y Change
+0.00%
Window
Jun 25, 2025 → Jun 18, 2026
- Market Cap
- $290.00M
- Revenue Growth
- -4.0%
- EPS Growth
- -27.2%
- Dividend Yield
- 4.2%
Coverage: 253 bars · Jun 25, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
COLTENE HOLDING AG (CLHLF) is a Healthcare stock with a market cap of $290.00M and listed on OTC. The stock last traded around $61.16 and up 0.0% across the available one-year price window (Jun 25, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of -4.0%, EPS growth of -27.2%, a dividend yield of 4.2%. What stands out right now is revenue -4.0%, EPS -27.2%, free cash flow -66.3% with operating margin 8.8% and ROIC 10.7%. The dividend matters to the case here, with a current yield around 4.2%. Valuation is more restrained than many high-expectation growth names at P/E 19.2 and price/sales 1.2. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines CLHLF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-4.0% vs +7.6% peer median
Operating Margin
Below sector median
+8.8% vs +19.4% peer median
P/E
Below sector median
19.2 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report landed above expectations
Q2 2026 was reported on Apr 29, 2026 with an EPS surprise of +11.1%.
The operating picture looks softer than before
Revenue is at -4.0% and EPS is at -27.2%, with operating margin around 8.8%.
The next real check-in already has a date
The next earnings event is scheduled for Jul 30, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 2 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS Δ | 1D | 5D | 20D |
|---|---|---|---|---|
Q2 2026 Apr 29, 2026 | +11.1% | +0.0% | +0.0% | +0.0% |
Q1 2026 Mar 16, 2026 | +30.3% | +0.0% | +0.0% | +0.0% |
Benchmark Edge
CLHLF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CLHLF
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CLHLF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for CLHLF and SPY.
Company Overview
COLTENE HOLDING AG
OTC
Coltene Holding AG is a Switzerland-based company specializing in the development, manufacture, and sale of consumables, disposables, tools, and small equipment for dentists and dental laboratories worldwide. Headquartered in Altstätten, it serves markets across Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania, targeting the dynamic CHF 14.4 billion dental consumables segment within the broader CHF 23.9 billion global dental market. The company offers comprehensive product lines spanning six key areas: endodontics with root canal files, rinsing solutions, obturation systems, and endo motors; restorative fillings including composites, adhesives, etching gels, and curing lights; prosthetics featuring impression materials like A-silicones and retractions; treatment auxiliaries such as dental dams, scalers, and aspirator tips; infection control products including ultrasonic cleaners and disinfectants; and rotary instruments like diamond burs and polishers. Coltene Holding AG pursues an 'Upgrade Dentistry' mission, innovating to enhance treatment efficiency, safety, and reliability in practices and labs through acquisitions and partnerships that bolster its technological edge and geographic presence. With around 1,176 employees, it focuses on demographic-driven growth, rising dental health awareness, and expanding access in emerging markets.
- Leadership
- Mr. Ahmed Khaled El-Hoshy
- Employees
- 1.2k
- Street Address
- Feldwiesenstrasse 20, 11 Bermudiana Road
- Mailing
- Altstätten, MI, 9450
- Region
- Altstätten, MI, Switzerland
- Last Updated
- May 8, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 19.2
- EV/EBITDA
- 11.3
- Price/Sales
- 1.2
- Price/Book
- 2.8
Growth
- Revenue
- -4.0%
- EPS
- -27.2%
- Free Cash Flow
- -66.3%
Profitability
- Gross Margin
- 62.1%
- Operating Margin
- 8.8%
- Net Margin
- 6.2%
- ROE
- 15.6%
- ROIC
- 10.7%
Balance Sheet
- Debt/Equity
- 0.47
- Current Ratio
- 1.53
Ownership & Float
- Float
- 2.58M
- Insider Owned
- 56.6%
- Institutional Owned
- 17.0%
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.